No doctor necessary: US okays nasal spray flu vaccine for self-use
Starting next fall, AstraZeneca's FluMist, which was authorized in 2003 to be administered by a healthcare provider, will be available to ordinary Americans through an online pharmacy.
This handout image obtained September 20, 2024 courtesy of AstraZeneca shows the FDA approved intranasal FluMist Influenza vaccine. (Photo by AstraZeneca / AFP)